Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Cole

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacokinetics|April 5, 2011
Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modellingHannah M Jones, Iain B Gardner, Wendy T Collard, et al.
Malaria Journal|September 28, 2024
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cureNada Abla, Anne Claire Marrast, Elodie Jambert, et al.
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
Bioorganic & Medicinal Chemistry|November 22, 2011
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokineticsDavid J Rawson, Stephen Ballard, Christopher Barber, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 28, 2017
Commentary on the MID3 Good Practices PaperEfthymios Manolis, Jacob Brogren, Susan Cole, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and ChallengesJames W T Yates, Michael Zientek, Kunal S Taskar, et al.
Journal of Medicinal Chemistry|March 25, 2010
Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humansMark I Lansdell, David Hepworth, Andrew Calabrese, et al.
The Lancet. HIV|August 7, 2025
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi processChloe Orkin, Amy Paterson, Alexa Elias, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacokinetics|April 5, 2011
Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modellingHannah M Jones, Iain B Gardner, Wendy T Collard, et al.
Malaria Journal|September 28, 2024
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cureNada Abla, Anne Claire Marrast, Elodie Jambert, et al.
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
Bioorganic & Medicinal Chemistry|November 22, 2011
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokineticsDavid J Rawson, Stephen Ballard, Christopher Barber, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 28, 2017
Commentary on the MID3 Good Practices PaperEfthymios Manolis, Jacob Brogren, Susan Cole, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and ChallengesJames W T Yates, Michael Zientek, Kunal S Taskar, et al.
Journal of Medicinal Chemistry|March 25, 2010
Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humansMark I Lansdell, David Hepworth, Andrew Calabrese, et al.
The Lancet. HIV|August 7, 2025
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi processChloe Orkin, Amy Paterson, Alexa Elias, et al.
Pageof 4